Early redemption of convertible bonds (incl. overseas CBs)

What happened

ST Pharm / Early Redemption of Convertible Bonds (Including Overseas CBs) After Issuance / (2026.08.11) Early Redemption of Convertible Bonds (Including Overseas CBs) After Issuance

Convertible Bonds (Including Overseas CBs), 2nd Series

1. Details of the bonds redeemed before maturity Bond type: Unregistered, non-interest-bearing, unsecured, privately placed convertible bonds Issue date: 2023-08-09 Issuance method: Domestic issuance (private placement) Conversion price per share (KRW): 79,648 Maturity date: 2028-08-09

2. Redemption amount (currency): 30,444,549,260 KRW (South Korean Won) - Face value (electronically registered) amount of bonds redeemed (currency): 30,000,000,000 KRW (South Korean Won) - Applicable exchange rate: - - Redemption date: 2026-08-10

3. Face value (electronically registered) amount of bonds outstanding after redemption (currency): 21,100,214,336 KRW (South Korean Won)

4. Reason for redemption before maturity and future treatment 1) KRW 29.55 billion - Reason: Exercise of the issuer's call option - Future treatment: To be determined at a future board meeting 2) KRW 0.45 billion - Reason: Bondholder's exercise of a put option (early redemption request) - Future treatment: Cancellation of the registered bonds at the Korea Securities Depository

5. Source of redemption funds: Company's own funds 6. Method of redemption: Over-the-counter purchase

7. Other matters for investment decisions - The redemption amount in item 2 includes both principal and interest. - The redemption date in item 2 is the payment date for the redemption amount.

Related disclosures: 2023-08-07 Decision to issue convertible bonds (2nd series) 2024-02-14 Adjustment of conversion price 2024-08-09 Adjustment of conversion price